Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Laboratory-developed Testing Market by Type (Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types), By Application (Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Laboratory-developed Testing Market by Type (Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types), By Application (Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130015 3300 Pharma & Healthcare 377 234 Pages 4.9 (50)
                                          

Industry Growth Insights published a new data on “Laboratory-developed Testing Market”. The research report is titled “Laboratory-developed Testing Market research by Types (Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types), By Applications (Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities), By Players/Companies Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics, Biodesix, Helix”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Laboratory-developed Testing Market Research Report

By Type

Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types

By Application

Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities

By Companies

Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics, Biodesix, Helix

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

234

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Laboratory-developed Testing Industry Outlook


Global Laboratory-developed Testing Market Report Segments:

The global Laboratory-developed Testing market is segmented on the basis of:

Types

Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Adaptive Biotechnologies Corporation
  2. Quest Diagnostics
  3. Roche
  4. Illumina
  5. Qiagen
  6. Eurofins
  7. Guardant Health
  8. Biotheranostics
  9. Adaptive Biotechnologies
  10. Rosetta Genomics
  11. Biodesix
  12. Helix

Global Laboratory-developed Testing Market Overview


Highlights of The Laboratory-developed Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Clinical Biochemistry
    2. Critical Care
    3. Haematology
    4. Immunology
    5. Microbiology
    6. Molecular Diagnostics
    7. Other Test Types
  1. By Application:

    1. Academic Institutes
    2. Clinical Research organizations
    3. Hospitals laboratory
    4. Specialty Diagnostic Centers
    5. Other Type of Facilities
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Laboratory-developed Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Laboratory-developed Testing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Laboratory-developed Testing Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Laboratory-developed Testing Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Laboratory-developed Testing Market - Supply Chain
   4.5. Global Laboratory-developed Testing Market Forecast
      4.5.1. Laboratory-developed Testing Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Laboratory-developed Testing Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Laboratory-developed Testing Market Absolute $ Opportunity

5. Global Laboratory-developed Testing Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Laboratory-developed Testing Market Size and Volume Forecast by Type
      5.3.1. Clinical Biochemistry
      5.3.2. Critical Care
      5.3.3. Haematology
      5.3.4. Immunology
      5.3.5. Microbiology
      5.3.6. Molecular Diagnostics
      5.3.7. Other Test Types
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Laboratory-developed Testing Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Laboratory-developed Testing Market Size and Volume Forecast by Application
      6.3.1. Academic Institutes
      6.3.2. Clinical Research organizations
      6.3.3. Hospitals laboratory
      6.3.4. Specialty Diagnostic Centers
      6.3.5. Other Type of Facilities
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Laboratory-developed Testing Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Laboratory-developed Testing Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Laboratory-developed Testing Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Laboratory-developed Testing Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Laboratory-developed Testing Demand Share Forecast, 2019-2029

9. North America Laboratory-developed Testing Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Laboratory-developed Testing Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Laboratory-developed Testing Market Size and Volume Forecast by Application
      9.4.1. Academic Institutes
      9.4.2. Clinical Research organizations
      9.4.3. Hospitals laboratory
      9.4.4. Specialty Diagnostic Centers
      9.4.5. Other Type of Facilities
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Laboratory-developed Testing Market Size and Volume Forecast by Type
      9.7.1. Clinical Biochemistry
      9.7.2. Critical Care
      9.7.3. Haematology
      9.7.4. Immunology
      9.7.5. Microbiology
      9.7.6. Molecular Diagnostics
      9.7.7. Other Test Types
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Laboratory-developed Testing Demand Share Forecast, 2019-2029

10. Latin America Laboratory-developed Testing Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Application
      10.4.1. Academic Institutes
      10.4.2. Clinical Research organizations
      10.4.3. Hospitals laboratory
      10.4.4. Specialty Diagnostic Centers
      10.4.5. Other Type of Facilities
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Type
      10.7.1. Clinical Biochemistry
      10.7.2. Critical Care
      10.7.3. Haematology
      10.7.4. Immunology
      10.7.5. Microbiology
      10.7.6. Molecular Diagnostics
      10.7.7. Other Test Types
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Laboratory-developed Testing Demand Share Forecast, 2019-2029

11. Europe Laboratory-developed Testing Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Laboratory-developed Testing Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Laboratory-developed Testing Market Size and Volume Forecast by Application
      11.4.1. Academic Institutes
      11.4.2. Clinical Research organizations
      11.4.3. Hospitals laboratory
      11.4.4. Specialty Diagnostic Centers
      11.4.5. Other Type of Facilities
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Laboratory-developed Testing Market Size and Volume Forecast by Typ
      11.7.1. Clinical Biochemistry
      11.7.2. Critical Care
      11.7.3. Haematology
      11.7.4. Immunology
      11.7.5. Microbiology
      11.7.6. Molecular Diagnostics
      11.7.7. Other Test Types
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Laboratory-developed Testing Demand Share, 2019-2029

12. Asia Pacific Laboratory-developed Testing Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Application
      12.4.1. Academic Institutes
      12.4.2. Clinical Research organizations
      12.4.3. Hospitals laboratory
      12.4.4. Specialty Diagnostic Centers
      12.4.5. Other Type of Facilities
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Type
      12.7.1. Clinical Biochemistry
      12.7.2. Critical Care
      12.7.3. Haematology
      12.7.4. Immunology
      12.7.5. Microbiology
      12.7.6. Molecular Diagnostics
      12.7.7. Other Test Types
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Laboratory-developed Testing Demand Share, 2019-2029

13. Middle East & Africa Laboratory-developed Testing Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Application
      13.4.1. Academic Institutes
      13.4.2. Clinical Research organizations
      13.4.3. Hospitals laboratory
      13.4.4. Specialty Diagnostic Centers
      13.4.5. Other Type of Facilities
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Type
      13.7.1. Clinical Biochemistry
      13.7.2. Critical Care
      13.7.3. Haematology
      13.7.4. Immunology
      13.7.5. Microbiology
      13.7.6. Molecular Diagnostics
      13.7.7. Other Test Types
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Laboratory-developed Testing Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Laboratory-developed Testing Market: Market Share Analysis
   14.2. Laboratory-developed Testing Distributors and Customers
   14.3. Laboratory-developed Testing Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Adaptive Biotechnologies Corporation
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Quest Diagnostics
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Roche
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Illumina
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Qiagen
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Eurofins
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Guardant Health
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Biotheranostics
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Adaptive Biotechnologies
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Rosetta Genomics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Biodesix
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Helix
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.2

Our Trusted Clients

Contact Us